Clinical Applications of Bone Marrow-Derived Mesenchymal Stem Cells
June 17, 2021While next generation cell-based treatments like CAR-T immunotherapies have been the source of much excitement and clinical investment in recent years, cellular therapies have a long, established history in the […]
FAQ Series: What is the difference between Buffy Coat and Leukapheresis?
June 2, 2021Welcome to the first installment of the FAQ series here on the AllCells blog where we will answer some key questions relating to hematological tissue products. Today, we will unpack […]
Good Manufacturing Practices (GMP) Facilitates Good Products
May 7, 2021With the FDA approvals of several cell therapy products (Kymriah® and Yescarta®) and many more cell therapies progressing towards clinical trials, sourcing high-quality cellular materials has become a critical determinant […]
Harnessing the Power of Natural Killer Cells for Cancer Immunotherapy
April 14, 2021The immune system is our body’s biological defense system against a variety of pathogens and is separated into the innate and adaptive branches. Our innate immune system is the body’s […]
CD14+ Monocytes are a Critical Component of the Innate Immune System
February 22, 2021What are Monocytes? Hematopoietic stem cells (HSCs), which reside in the bone marrow give rise to blood cells in a process called hematopoiesis. HSCs differentiate into the lymphoid and myeloid […]
PBMCs: A powerful research tool
October 28, 2020What are PBMCs? Human peripheral blood mononuclear cells (PBMCs) are key components of the body’s complex and dynamic immune system. A mononuclear cell is characterized by a single round nucleus […]
Maintain Flexibility in your Workflow without Compromising Quality – Cryopreserved Leukopaks
September 15, 2020Alameda, CA – September 15, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today the addition of Cryopreserved Leukopaks […]
AllCells Announces Expanded Product Portfolio, Guaranteed Cell-Count Leukopaks
August 17, 2020Alameda, CA – August 13, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today that it has expanded its […]
Chimeric Antigen Receptor (CAR) T-Cell Therapy
July 20, 2020Re-tasking our body’s own immune system to treat cancer has been a major scientific goal over the last few decades. According to the National Cancer Institute, it is estimated that […]
Mobilized Peripheral Blood: Maximize Your CD34+ Yield
July 8, 2020Hematopoietic stem and progenitor cells (HSPCs) are primarily found in the bone marrow, which is the main site of hematopoiesis in humans. The CD34 marker is most commonly associated with […]
